Fulda S
Institute for Experimental Cancer Research in Pediatrics, Goethe-University, Komturstrasse 3a, Frankfurt am Main, Germany.
Klin Padiatr. 2010 Nov;222(6):340-4. doi: 10.1055/s-0030-1265169. Epub 2010 Sep 22.
One of the hallmarks of human cancers is the deregulation of signal transduction pathways that regulate fundamental processes such as cell proliferation and cell death. This leads to the disturbance in the physiological control of tissue homeostasis and a concomitant net increase in cell number. Thus, deregulation of intracellular signaling events can contribute to tumorigenesis and tumor progression. In addition, this may also confer treatment resistance, since the response of cancer cells towards most cytotoxic therapies including chemo-, radio- or immunotherapy critically depends on intact signaling cascades that eventually lead to cell death. Hence, a better understanding of the molecular mechanisms that regulate cell death and survival programs in cancer cells is expected to provide the basis for the development of new diagnostic and therapeutic strategies.
人类癌症的标志之一是调节细胞增殖和细胞死亡等基本过程的信号转导通路失调。这会导致组织稳态生理控制的紊乱以及细胞数量的相应净增加。因此,细胞内信号事件的失调可促进肿瘤发生和肿瘤进展。此外,这也可能导致治疗耐药,因为癌细胞对包括化疗、放疗或免疫治疗在内的大多数细胞毒性疗法的反应严重依赖于最终导致细胞死亡的完整信号级联。因此,更好地理解调节癌细胞中细胞死亡和存活程序的分子机制有望为开发新的诊断和治疗策略提供基础。